Skip to main content

Want a detailed portfolio tracker?

Lexeo Therapeutics (LXEO) P/E (2024 - 2026)

Lexeo Therapeutics (LXEO) P/E from Jan 2, 2024 to Jun 3, 2026. The TTM Lexeo Therapeutics (LXEO) P/E is -1.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Lexeo Therapeutics (LXEO)

YearP/EChange
2026-1.80-41.76%
2025-3.10+40.12%
2024-2.21N/A

Comparison Lexeo Therapeutics (LXEO) P/E with competitors

Lexeo Therapeutics (LXEO) P/E is -1.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.09%
NBYStablecoin Development Corp0.10-105.67%
ENLVEnlivex Therapeutics Ltd0.15-108.33%
FGENFibroGen Inc0.24-113.31%
TRAWTraws Pharma Inc0.47-126.21%
FBIOFortress Biotech Inc0.71-139.14%
CHRSCoherus Biosciences Inc0.98-154.23%
ORMPOramed Pharmaceuticals Inc1.47-181.69%
AGENAgenus Inc2.05-213.57%
VIVSVivoSim Labs Inc2.54-240.59%
INVAInnoviva Inc3.19-276.78%
CRMDCorMedix Inc3.65-302.13%
ABEOAbeona Therapeutics Inc4.20-333.14%
VXRTVaxart Inc4.26-336.28%
CVACCureVac N.V.4.45-346.48%
SRPTSarepta Therapeutics Inc4.62-356.38%
GLPGGalapagos NV4.86-369.39%
RIGLRigel Pharmaceuticals4.92-372.75%
ZVRAZevra Therapeutics Inc4.97-375.78%
ABUSArbutus Biopharma Corp5.69-415.68%
CGENCompugen Ltd7.38-509.39%
AUPHAurinia Pharmaceuticals Inc9.25-612.93%
ACADAcadia Pharmaceuticals Inc9.59-631.60%
OMEROmeros Corporation9.88-647.98%
PLXProtalix BioTherapeutics Inc9.91-649.40%
SPROSpero Therapeutics Inc10.73-695.18%
ADMAAdma Biologics Inc11.33-728.21%
SVASinovac Biotech Ltd11.44-734.06%
TBPHTheravance Biopharma Inc11.78-752.94%
HRMYHarmony Biosciences Holdings Inc12.18-775.33%
TGTXTG Therapeutics Inc13.18-830.72%
INCYIncyte Corp13.38-841.95%
SABSSAB Biotherapeutics Inc14.06-879.42%
XOMAXOMA Corp14.95-928.62%
REGNRegeneron Pharmaceuticals Inc14.98-930.57%
PBYIPuma Biotechnology Inc15.05-934.46%
EXELExelixis Inc15.79-975.73%
NAGENiagen Bioscience Inc16.35-1006.79%
CPRXCatalyst Pharmaceuticals Inc17.34-1061.66%
MDXGMimedx Group Inc17.38-1063.36%
ARGXArgen X SE23.07-1379.18%
HALOHalozyme Therapeutics Inc23.20-1386.34%
XOMAOXOMA Corp25.34-1505.22%
VRTXVertex Pharmaceuticals Inc25.66-1522.46%
XOMAPXOMA Corp25.67-1523.26%
CTMXCytomX Therapeutics Inc25.70-1524.80%
ASNDAscendis Pharma A/S26.35-1561.18%
RPRXRoyalty Pharma plc - Class A27.50-1624.46%
SLNOSoleno Therapeutics Inc29.02-1708.73%
LGNDLigand Pharmaceuticals Inc - Class B30.19-1773.67%
BMRNBiomarin Pharmaceutical Inc37.51-2179.56%
APLSApellis Pharmaceuticals Inc39.02-2263.50%
KRYSKrystal Biotech Inc39.70-2301.00%
GMABGenmab40.20-2329.06%
ONCBeiGene Ltd67.03-3816.26%
TECHBio-Techne Corp68.59-3903.20%
VCELVericel Corp80.63-4570.42%
PHARPharming Group N.V.87.74-4964.69%
ALNYAlnylam Pharmaceuticals Inc124.93-7026.85%
TLXTelix Pharmaceuticals Ltd139.89-7856.13%
CORTCorcept Therapeutics Inc158.39-8881.77%